Vineet Laboratories has received regulatory approval to extend the deadline for holding its 10th Annual General Meeting by two months.

The Registrar of Companies, Hyderabad, granted the extension on September 17, 2026, allowing the company to hold the meeting by November 30, 2026. This follows an application filed by the company on September 4, 2026, citing operational requirements for additional time.

Regulatory Context

The extension was granted under Section 96(1) of the Companies Act, 2013. The original statutory deadline for the AGM, covering the financial year ended March 31, 2026, was September 30, 2026.

The ROC order advises the company to ensure strict compliance with statutory timelines in future filings. The approval letter was received by the company on September 18, 2026.

Next Steps

The Board of Directors will convene to finalize the date, time, and venue for the extended AGM. Key disclosures required under SEBI Listing Regulations include:

• Notice convening the meeting
• Record date for remote e-voting eligibility
• Annual Report for FY25

These details will be submitted to the BSE and NSE within the prescribed timelines following the board's decision.

The Board of Directors of Vineet Laboratories approved audited standalone financial results for the fourth quarter and fiscal year ended March 31, 2026, on August 25, 2026.

The company reported a net profit of ₹72.51 lakh for Q4FY26, a significant turnaround from the net loss of ₹1,052.51 lakh recorded in the same quarter last year. For the full fiscal year, Vineet Laboratories posted a net profit of ₹111.08 lakh, reversing a net loss of ₹2,019.10 lakh in FY25.

Financial Performance

Revenue from operations for Q4FY26 stood at ₹1,889.14 lakh, up from ₹1,407.65 lakh in Q4FY25. However, total revenue for FY26 declined to ₹5,940.10 lakh from ₹7,499.50 lakh in the previous year.

Profit before tax for the quarter was ₹99.46 lakh compared to a loss of ₹1,122.13 lakh in Q4FY25. For the full year, profit before tax was ₹128.27 lakh against a loss of ₹2,077.55 lakh in FY25.

What the Numbers Show

A key driver behind the improved profitability in FY26 was a substantial reduction in other expenses. Other expenses fell to ₹821.77 lakh in FY26 from ₹1,570.39 lakh in FY25. This decline occurred alongside a decrease in cost of materials consumed, which dropped to ₹6,188.34 lakh from ₹6,376.84 lakh in the prior year, helping offset lower revenue.

Balance Sheet and Borrowings

As of March 31, 2026, total assets stood at ₹12,478.34 lakh, up from ₹9,454.01 lakh in the previous year. Current assets increased significantly to ₹9,882.92 lakh from ₹6,739.38 lakh, driven by higher inventories of ₹6,409.07 lakh and cash and cash equivalents of ₹1,669.52 lakh.

Outstanding long-term borrowings decreased to ₹35.29 crore at the end of FY26 from ₹39.09 crore at the start of the year. The company confirmed it did not undertake any incremental qualified borrowings or issue debt securities during the year.

Auditor Opinion

Statutory Auditors NSVR & Associates LLP issued an unmodified opinion on the standalone financial results for the year ended March 31, 2026.